Not applicableLooking for participantsNCT07125079
What this trial is testing
Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.
Who this might be right for
ARDS (Acute Respiratory Distress Syndrome)
University of Pennsylvania 36